Does FDA reject nonclinical laboratory studies that have not been conducted in full compliance with the GLPs?

Not necessarily. The GLP Compliance Program provides guidance on the issue. For FDA
to reject a study, it is necessary to find that there were deviations from the GLPs and that
these deviations were of such a nature as to compromise the quality and integrity of the
study covered by the agency inspection.